Long-Lasting In Vivo Effects of the Cannabinoid CB1 Antagonist AM6538

The Journal of Pharmacology and Experimental Therapeutics
C A ParonisJack Bergman

Abstract

AM6538 is a cannabinoid antagonist that binds CB1 receptors expressed in HEK-293 cells in a wash-resistant manner. The effects of AM6538 in live animals has not previously been established. We characterized the antagonist effects of AM6538 in male mice, using a warm-water tail-withdrawal assay, and in male squirrel monkeys trained to discriminate the CB1 agonist AM4054 from vehicle. The cannabinoid agonists WIN 55,212, Δ9-tetrahydrocannabinol (THC), and AM4054 all produced 100% maximum possible antinociceptive effects in mice following vehicle pretreatment. One-hour pretreatment with increasing doses of AM6538 (0.1-10 mg/kg) produced first rightward, then downward shifts of the agonist dose-effect functions. Rimonabant, 1-10 mg/kg, produced parallel rightward shifts of the AM4054 dose-effect functions, and baseline effects of AM4054 were nearly recovered within 24 hours following 10 mg/kg of rimonabant. In contrast, in mice treated with 10 mg/kg of AM6538, antagonism of THC or AM4054 lasted up to 7 days. AM6538 also antagonized the discriminative stimulus effects of AM4054 in squirrel monkeys in a dose-related manner, and the effects of 3.2 mg/kg of AM6538 endured for more than 7 days. The effective reduction in CB1 receptor re...Continue Reading

References

Mar 1, 1989·British Journal of Pharmacology·P Leff, I G Dougall
Jul 28, 1999·European Journal of Pharmacology·F PetitetA Imperato
Oct 19, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Sophie J GovaertsDidier M Lambert
May 10, 2011·Journal of Biomolecular Screening·Sarah A NickollsRoss A Kinloch
Nov 24, 2011·Pharmacology, Biochemistry, and Behavior·Priyanka A MadiaByron C Yoburn
Oct 19, 2012·Behavioural Pharmacology·Carol A ParonisAlexandros Makriyannis
Jan 5, 2013·The Journal of Pharmacology and Experimental Therapeutics·Brian D KangasJack Bergman
May 28, 2016·The Journal of Pharmacology and Experimental Therapeutics·Girish R ChopdaCarol A Paronis
Oct 22, 2016·Cell·Tian HuaZhi-Jie Liu
Jan 20, 2017·ACS Chemical Neuroscience·Robert B LaprairieGanesh A Thakur

❮ Previous
Next ❯

Citations

Feb 27, 2021·Bioorganic & Medicinal Chemistry Letters·Thanh C HoAlexandros Makriyannis
May 2, 2021·Pharmacology, Biochemistry, and Behavior·Jenny L WilkersonLance R McMahon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Pharmacology
Girish R ChopdaC A Paronis
The Journal of Pharmacology and Experimental Therapeutics
Brian D KangasJack Bergman
The Journal of Pharmacology and Experimental Therapeutics
C A ParonisJack Bergman
© 2022 Meta ULC. All rights reserved